Other languages Scancell Holdings plc

Equities

Market Closed - London S.E. Other stock markets 11:35:20 2024-05-08 am EDT			5-day change	1st Jan Change
9.875 ^GBX	+5.05%		+6.76%	-5.95%

Mar. 26	Scancell doses first patient in melanoma-focused trials	AN
Mar. 22	Seneca Growth Capital announces tepid 2023 results	AN

Scancell doses first patient in melanoma-focused trials	Mar. 26
Seneca Growth Capital announces tepid 2023 results	Mar. 22
Scancell Holdings plc Appoints Sath Nirmalananthan to the Board	Mar. 14
Alliance Pharma appoints chair; FireAngel sales down	Feb. 05
Scancell's Chief Development Officer to Step Down	Feb. 05
Scancell Holdings plc Directorate and Executive Changes Changes	Feb. 05
Scancell interim loss narrows amid finance gain on derivative	Jan. 30
Scancell Holdings plc Reports Earnings Results for the Half Year Ended October 31, 2023	Jan. 30
Scancell approved by MHRA to add new cohort to Scope trial	Jan. 17
Scancell Holdings plc Announces Update on SCOPE Trial	Jan. 17
Scancell Raises GBP1.2 Million Via Open Offer	Dec. 19
Scancell raises GBP12 million in total from fundraise	Dec. 19
Scancell Raises GBP11 Million via Share Issue	Dec. 01
Scancell raises GBP10.7 million in upsized share sale	Dec. 01
EARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widen	Nov. 30
Scancell’s Skin Cancer Vaccine Trial Advances to Second Stage; Shares Up	Nov. 28
Scancell trial progresses; OptiBiotix inks new deal	Nov. 28
Scancell shares up as presents "trailblazing" trial data	Nov. 10
EARNINGS: Frontier IP chair to step down; "busy" Rosslyn narrows loss	23-10-31
Earnings Flash (SCLP.L) SCANCELL HOLDINGS Reports FY23 Revenue GBP5.3M	23-10-31

No results for this search